Aug 12,2015

Insulet Reports Second Quarter 2015 Financial Results

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three months ended June 30, 2015. Second quarter 2015 revenue increased 5% to $75.6 million, compared with $72.0 million in the second quarter of 2014.

View Analyst & Ambassador Comments
Go to original news
Aug 13,2015

LabStyle Innovations Announces 2015 Second Quarter Results

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today reported financial and operational results for the three-month period ended June 30, 2015, provided an update on recent corporate achievements, and an outlook on upcoming milestones. LabStyle's revenues for the second quarter of 2015 amounted to approximately $175,000 compared to approximately $67,000 in the previous quarter and none in the second quarter of 2014.

View Analyst & Ambassador Comments
Go to original news
Aug 24,2015

FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System

Dexcom announced today that the U.S. Food and Drug Administration (FDA) has approved the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System. With wireless Bluetooth® technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver. The new transmitter securely sends vital glucose information directly to an app on iOS-enabled devices for real-time diabetes management. Android applications will follow early next year. Like its predecessor, the G4 PLATINUM CGM with Share, users can also select up to five designated recipients, or "followers”. These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere.

REGULATORY FDA

#cgm

View Analyst & Ambassador Comments
Go to original news
Aug 25,2015

LabStyle Innovations to Exhibit at Australian Diabetes Society's Annual Meeting on August 26 - 28, 2015

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that in conjunction with its Australian distributor, uHealth, the Company is exhibiting at the Australian Diabetes Society (ADS) and Australian Diabetes Educators Association's (ADEA) 2015 Annual Scientific Meeting and Exhibition in Adelaide, Australia. From Wednesday, August 26th through Friday, August 28th, at Booth #9 LabStyle will showcase the Dario Diabetes Management System. The Dario platform is a next generation technology that digitizes every testing event through a miniature meter powered directly by a smartphone via the audio jack turning an iOs or Android smartphone into a cloud-linked meter. In addition to having received regulatory approval in Australia, the Dario is CE marked in Europe and approved in Canada.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 26,2015

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences: 2015 Baird Healthcare Conference in New York, NY. The presentation will take place on Thursday, September 10, 2015 at 2:35pm Eastern Time (11:35am Pacific Time). 2015 Morgan Stanley Global Healthcare Conference in New York, NY. The presentation will take place on Thursday, September 17, 2015 at 2:55pm Eastern Time (11:55am Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 31,2015

LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million. Funds will be used to support the global rollout and initial U.S. commercial launch of the Dario, a mobile, cloud-based, diabetes management solution that includes novel software applications combined with a stylish, 'all-in-one,' pocket-sized, blood glucose monitoring device, and for working capital purposes. The Dario recently launched in Canada with reimbursement through a majority of medical plans and the U.S. Food and Drug Administration's clearance is anticipated in the coming months.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 15,2015

Philips launches an mHealth platform for type 1 diabetics

Philips has unveiled a new "connected digital health prototype" that's designed to help type 1 diabetics manage their health and connect with caregivers. the platform is a "collaboration space" for type 1 diabetics and healthcare providers, allowing access to data from electronic medical records and mobile devices, including blood glucose monitors and health and fitness monitors, as well as patient-entered data. Through a tablet, smartphone or other device, the user can access health data, receive health advice and alerts and communicate in real time with clinicians and other caregivers.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Sep 22,2015

Wellthy Provides Respite For Patients And Families Coping With Long-Term Health Conditions

Arranging appointments, researching new treatments, and filing insurance paperwork are just a few of the things patients and their loved ones have to manage every day. Wellthy, launching onstage today at the Disrupt SF Battlefield, wants to help. The startup’s marketplace makes it easier for patients to find pre-screened health providers in their area. Wellthy’s marketplace is designed for people who want to book specific services, but don’t know where to start, since many online doctor directories aren’t curated and don’t have reviews. For providers, Wellthy’s directory gives them an online presence where they can build their reputation through reviews and find more clients.

View Analyst & Ambassador Comments
Go to original news
Sep 23,2015

Joslin Diabetes Center to pilot test mobile app for Type 1 patients

Joslin Diabetes Center is running a small trial to pilot test a mobile health app and an online nutrition education platform for people with Type 1 diabetes, according to a ClinicalTrials.gov posting . The web platform will help educate patients about how to optimize their glucose and analyze their after-meal behavior. The app will facilitate data logging to help patients and caregivers track and explain variability in their glucose readings. The system is called “Sugar Sleuth”. The study will be a 3-month, 30-person, nonrandomized trial.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 29,2015

Medtronic launches smartphone connectivity for CGMs, insulin pumps

Medtronic has launched its MiniMed Connect system, which allows people with diabetes who use both a Medtronic continuous glucose monitor (CGM) and a Medtronic insulin pump to see data from both device on their smartphone, and send it to their caregiver. "It’s part of our plan to become a holistic diabetes management company," Annette Brüls, President of the Diabetes Service and Solutions business at Medtronic, told MobiHealthNews.

PRODUCT

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES